Feasibility of implementing the World Health Organization case management guideline for possible serious bacterial infection among young infants in Ntcheu district, Malawi.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 08 09 2019
accepted: 22 01 2020
entrez: 15 4 2020
pubmed: 15 4 2020
medline: 2 7 2020
Statut: epublish

Résumé

Neonatal sepsis is a leading cause of mortality, yet the recommended inpatient treatment options are inaccessible to most families in low-income settings. In 2015, the World Health Organization released a guideline for outpatient treatment of young infants (0-59 days of age) with possible serious bacterial infection (PSBI) with simplified antibiotic regimens when referral was not feasible. If implemented widely, this guideline could prevent many deaths. Our implementation research evaluated the feasibility and acceptability of implementing the WHO guideline through the existing health system in Malawi. A prospective cohort study was conducted in 12 first-level health facilities in Ntcheu district. Trained health workers identified and treated young infants with PSBI signs with injection gentamicin for 2 days and oral amoxicillin for 7 days, whereas those with only fast breathing were treated with oral amoxicillin for 7 days. Health Surveillance Assistants (HSAs) were trained to promote care-seeking and to conduct home visits on day 3 and 6 to assess infants under treatment, encourage treatment adherence and remind the caregiver to return for facility follow up. Infants receiving outpatient treatment were followed up at health facility on day 4 and 8. The primary outcome was proportion of outpatient cases completing treatment per protocol. A total of 358 infants received outpatient treatment (202 clinical severe infection, 156 only fast breathing) from February to September 2017. Of these, 92.7% (332/358) met criteria for treatment completion and 88.8% (318/358) completed the day 4 follow-up. Twelve (3.4%) young infants clinically failed treatment with no reported deaths in those treated at outpatient level. This treatment failure rate was lower than those reported for the simplified regimens tested in the SATT (8-10%) and AFRINEST (5-8%) equivalency trials. More than half of infants (58.1%; 208/358) received HSA follow-up visits on days 3 and 6. Study results demonstrate the feasibility of outpatient treatment for sick young infants when referral is not feasible in Malawi, which will inform scale-up in other parts of Malawi and countries with similar health system constraints.

Sections du résumé

BACKGROUND
Neonatal sepsis is a leading cause of mortality, yet the recommended inpatient treatment options are inaccessible to most families in low-income settings. In 2015, the World Health Organization released a guideline for outpatient treatment of young infants (0-59 days of age) with possible serious bacterial infection (PSBI) with simplified antibiotic regimens when referral was not feasible. If implemented widely, this guideline could prevent many deaths. Our implementation research evaluated the feasibility and acceptability of implementing the WHO guideline through the existing health system in Malawi.
METHODS
A prospective cohort study was conducted in 12 first-level health facilities in Ntcheu district. Trained health workers identified and treated young infants with PSBI signs with injection gentamicin for 2 days and oral amoxicillin for 7 days, whereas those with only fast breathing were treated with oral amoxicillin for 7 days. Health Surveillance Assistants (HSAs) were trained to promote care-seeking and to conduct home visits on day 3 and 6 to assess infants under treatment, encourage treatment adherence and remind the caregiver to return for facility follow up. Infants receiving outpatient treatment were followed up at health facility on day 4 and 8. The primary outcome was proportion of outpatient cases completing treatment per protocol.
FINDINGS
A total of 358 infants received outpatient treatment (202 clinical severe infection, 156 only fast breathing) from February to September 2017. Of these, 92.7% (332/358) met criteria for treatment completion and 88.8% (318/358) completed the day 4 follow-up. Twelve (3.4%) young infants clinically failed treatment with no reported deaths in those treated at outpatient level. This treatment failure rate was lower than those reported for the simplified regimens tested in the SATT (8-10%) and AFRINEST (5-8%) equivalency trials. More than half of infants (58.1%; 208/358) received HSA follow-up visits on days 3 and 6.
CONCLUSION
Study results demonstrate the feasibility of outpatient treatment for sick young infants when referral is not feasible in Malawi, which will inform scale-up in other parts of Malawi and countries with similar health system constraints.

Identifiants

pubmed: 32287262
doi: 10.1371/journal.pone.0229248
pii: PONE-D-19-25252
pmc: PMC7156088
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0229248

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

The authors declare that no competing interests exist. Some of the authors are currently and/or were previously employed by not-for-profit organizations including: Save the Children, World Health Organization, and ActionAid. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Lancet. 2015 May 2;385(9979):1767-1776
pubmed: 25842221
Pediatr Infect Dis J. 2013 Sep;32 Suppl 1:S33-8
pubmed: 23945574
J Glob Health. 2019 Jun;9(1):010808
pubmed: 31275568
Pediatr Infect Dis J. 2012 Jul;31(7):667-72
pubmed: 22481421
Lancet Glob Health. 2015 May;3(5):e279-87
pubmed: 25841891
Malawi Med J. 2014 Dec;26(4):126-32
pubmed: 26167263
J Perinatol. 2011 Sep;31(9):586-92
pubmed: 21273989
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
BMC Public Health. 2015 Sep 30;15:989
pubmed: 26419934
PLoS One. 2013 Jul 17;8(7):e68930
pubmed: 23874816

Auteurs

Tanya Guenther (T)

Unitaid, World Health Organization, Geneva, Switzerland.

Gladson Mopiwa (G)

The Joint TB/HIV Global Fund -ActionAid, Lilongwe, Malawi.

Humphreys Nsona (H)

IMCI Unit, Ministry of Health, Lilongwe, Malawi.

Shamim Qazi (S)

Department of Maternal Newborn Child and Adolescent Health, World Health Organization, Geneva, Switzerland.

Regina Makuluni (R)

District Health Office, Ministry of Health, Ntcheu, Malawi.

Chancy Banda Fundani (CB)

District Health Office, Ministry of Health, Ntcheu, Malawi.

Jenda Gomezgani (J)

Save the Children Malawi, Lilongwe, Malawi.

Leslie Mgalula (L)

World Health Organization, Lilongwe, Malawi.

Mike Chisema (M)

District Health Office, Ministry of Health, Ntcheu, Malawi.

Salim Sadruddin (S)

Global Malaria Program, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH